FORMAN ERIC 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 13, 2022

Insider Transaction Report

Form 4
Period: 2022-12-09
FORMAN ERIC
10% Owner
Transactions
  • Purchase

    Common Stock

    2022-12-09$0.63/sh+5,000$3,136(indirect: By Trust)
  • Purchase

    Common Stock

    2022-12-09$0.60/sh+10,000$6,000(indirect: By Trust)
  • Purchase

    Common Stock

    2022-12-09$0.63/sh+1,112$701(indirect: By Trust)
Holdings
  • Common Stock

Documents

1 file
  • 4
    ownership.xmlPrimary